Description
Mounjaro (tirzepatide) is used for type 2 diabetes to help lower blood sugar levels, and tirzepatide also causes weight loss. Mounjaro is a once-weekly injection that should be used alongside dietary changes and exercise. Mounjaro received FDA approval on May 13, 2022.
Mounjaro (tirzepatide)Â 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per 0.5 mL injection
Reviews
There are no reviews yet.